Cite
MLA Citation
Prajwal Boddu et al.. “Outcomes of patients with chronic phase chronic myeloid leukemia (CML-CP) after discontinuation of frontline ponatinib therapy.” Leukemia & lymphoma, vol. 60, no. 13, 2019, pp. 3172–3180. http://access.bl.uk/ark:/81055/vdc_100098636151.0x000038